Understanding the chain reaction of chronic diseases

Have you ever heard the saying, “When it rains, it pours”? That is what happens with chronic health conditions like diabetes, obesity, high blood pressure, and heart disease; they rarely show up alone. In fact, they often travel in packs, creating a domino effect that puts your entire health at risk.

But here’s the wonderful news: when you start to understand these connections, you can take control! By addressing one condition, you’re not only addressing that one, but taking the others head on too.

ET Spotlight

Dr. Saptarshi Bhattacharya, MD (MAMC), DM (AIIMS), FACE, Specialty Certificate RCP UK, Senior Consultant, Endocrinology, Indraprastha Apollo Hospitals, Delhi

The web of interlinked diseases
Let’s say someone is living with Type 2 diabetes. We already know this affects how the body processes sugar. But over time, that excess sugar in the blood doesn’t just stay there; it damages blood vessels and nerves.1-3 This damage can creep into the heart, kidneys, and even the feet.4-8 Moreover, if that same person is also carrying extra weight (especially around the belly), it can worsen insulin resistance, raise blood pressure, and raise harmful cholesterol levels.9 One condition amplifies the next, like a chain reaction inside your body.

This group of overlapping risks is sometimes called cardio-kidney-metabolic (CKM) syndrome, and it’s more common than you think. It includes heart disease, chronic kidney disease, and metabolic conditions like diabetes and obesity.10,11

Why treating conditions separately isn’t enough

Traditionally, people have been treated for each condition as if it exists in isolation. When it comes to the heart? Visit a cardiologist. Blood sugar? See your endocrinologist. Kidneys? That requires seeing a nephrologist.

But here’s the problem: your body doesn’t work in isolation! All organs and systems are in constant communication with each other. So, if we only focus on one part of the picture, the rest might be left a bit vulnerable. That’s why modern medicine is embracing a holistic approach, one that thoughtfully considers how all these systems interact. The power of blood sugar control and beyond

By keeping your blood sugar level in check, you’re not only helping your pancreas, but also easing the workload on your heart. This positive change can lower your risk of kidney damage and enhance circulation to your nerves.12,13

And it doesn’t stop there! Losing just a modest amount of weight, like 5-10% of your body weight, can boost insulin sensitivity, lower blood pressure, and help keep future complications at bay.14,15 Remember, small steps can reap big rewards.

Did you know your body has built-in helpers?
Here’s something fascinating: your body naturally produces a hormone called insulin & GLP-1.

Insulin is a hormone produced by the pancreas that helps regulate blood sugar by allowing glucose to enter cells for energy. It plays a crucial role in maintaining normal blood sugar levels, especially after meals.

GLP-1 hormone: Think of it as a smart signal that helps manage your blood sugar, slows down how fast food leaves your stomach, and even tells your brain when you’ve had enough to eat.16 Pretty neat, right?

But here’s the catch: if you have diabetes, this hormone doesn’t always work the way it should. And that’s when things can get off track. Therefore, understanding these hormones and how it works could be a real eye-opener for managing your health more effectively.17,18

If this sparks your curiosity, chat with your doctor. You don’t need to know all the science; just knowing the right questions to ask is a powerful first step.

WOD Logo (2) (1)ET Spotlight

Take the first step: Talk to your doctor
You don’t need to become a medical expert to take back control of your health. But you do need to start the conversation. If you’ve been diagnosed with diabetes, high blood pressure, kidney problems, or obesity, or even just one of these, it’s time to talk to your doctor about the full picture.

Ask questions like:
How are these conditions connected in my case? What can I do to manage them together? Are there newer treatments or strategies I should know about?

Because here’s the truth: Your health isn’t just a collection of isolated issues. It’s a connected, living system, and when you care for one part, you’re caring for it all.

Conclusion
It’s time to stop treating chronic conditions as separate chapters in your health story. They’re all part of the same plot; you hold the pen. So let’s write a new chapter where you’re informed, empowered, and supported every step of the way.

Key takeaways

  • Chronic conditions are connected: Diabetes, obesity, heart, and kidney issues often show up together and affect each other.
  • One small step equals a giant leap for holistic health: Managing blood sugar levels along with weight management can improve heart, kidney, and nerve health.
  • Your body has intelligent support: The hormone GLP-1 naturally aids in regulating blood sugar, appetite, and digestion, but may require assistance in managing diabetes.
  • Talk to your doctor: Understanding how your conditions connect can lead to better, more holistic care.

References:

  1. Brown OI, Drozd M, McGowan H, Giannoudi M, Conning-Rowland M, Gierula J, Straw S, Wheatcroft SB, Bridge K, Roberts LD, Levelt E, Ajjan R, Griffin KJ, Bailey MA, Kearney MT, Cubbon RM. Relationship Among Diabetes, Obesity, and Cardiovascular Disease Phenotypes: A UK Biobank Cohort Study. Diabetes Care. 2023;46(8):1531-1540.
  2. Koirala S, Sunnaa M, Bernier T, et al. The Role of Obesity as a Cardiac Disease Risk Factor in Patients with Type 2 Diabetes. Curr Cardiol Rep. 2024;26:1309-1320.
  3. Sharma, A., Mittal, S., Aggarwal, R. et al. Diabetes and cardiovascular disease: inter-relation of risk factors and treatment. Futur J Pharm Sci. 2020;6:130.
  4. Kovesdy CP, Furth SL, Zoccali C, on behalf of the World Kidney Day Steering Committee. Obesity and Kidney Disease: Hidden Consequences of the Epidemic. Am J Hypertens. 2017;30(3):328-336.
  5. Townsend KL. One Nervous System: Critical Links Between Central and Peripheral Nervous System Health and Implications for Obesity and Diabetes. Diabetes. 2024;73(12):1967-1975.
  6. Callaghan BC, Reynolds E, Banerjee M, Chant E, Villegas-Umana E, Feldman EL. Central Obesity is Associated With Neuropathy in the Severely Obese. Mayo Clin Proc. 2020;95(7):1342-1353.
  7. Lim, J.Z.M., Burgess, J., Ooi, C.G. et al. The Peripheral Neuropathy Prevalence and Characteristics Are Comparable in People with Obesity and Long-Duration Type 1 Diabetes. Adv Ther. 2022;39:4218–4229.
  8. Man REK, Sabanayagam C, Chiang PP, et al. Differential Association of Generalized and Abdominal Obesity With Diabetic Retinopathy in Asian Patients With Type 2 Diabetes. JAMA Ophthalmol. 2016;134(3):251-257.
  9. Zyoud, S.H., Shakhshir, M., Abushanab, A.S. et al. Global research trends on the links between insulin resistance and obesity: a visualization analysis. transl med commun. 2022;7:18.
  10. Chiadi E. Ndumele, Ian J. Neeland, et al. A Synopsis of the Evidence for the Science and Clinical Management of Cardiovascular Kidney-Metabolic (CKM) Syndrome: A Scientific Statement From the American Heart Association. Circulation. 2023;148:1636–1664.
  11. Mutruc V, Bologa C, Șorodoc V, Ceasovschih A, Morărașu BC, Șorodoc L, Catar OE, Lionte C. Cardiovascular–Kidney–Metabolic Syndrome: A New Paradigm in Clinical Medicine or Going Back to Basics? Journal of Clinical Medicine. 2025;14(8):2833.
  12. The ADVANCE Collaborative Group. Intensive Blood Glucose Control and Vascular Outcomes in Patients with Type 2 Diabetes. N Engl J Med 2008;358:2560-2572.
  13. Sophia Zoungas, John Chalmers, et al. Follow-up of Blood-Pressure Lowering and Glucose Control in Type 2 Diabetes. N Engl J Med. 2014;371:1392-1406.
  14. LD Clamp, DJ Hume, EV Lambert and J Kroff. Enhanced insulin sensitivity in successful, long-term weight loss maintainers compared with matched controls with no weight loss history. Nutrition & Diabetes. 2017;7:e282.
  15. Tahrani, A. A., & Morton, J. Benefits of weight loss of 10% or more in patients with overweight or obesity: A review. Obesity (Silver Spring, Md.). 2022;30(4):802–840.
  16. Paternoster S and Falasca M Dissecting the Physiology and Pathophysiology of Glucagon-Like Peptide-1. Front. Endocrinol. 2018;9:584.
  17. Ilias I, Zabuliene L and Rizzo M. GLP-1 receptor agonists in diabetes and weight loss: the double-edged sword of innovation and risks. Front. Clin. Diabetes Healthc. 2025;5:1530811.
  18. Zhang, X., Cao, C., Zheng, F. et al. Therapeutic Potential of GLP-1 Receptor Agonists in Diabetes and Cardiovascular Disease: Mechanisms and Clinical Implications. Cardiovasc Drugs Ther. 2025.

Disclaimer: This content is part of a disease awareness initiative by Novo Nordisk. The opinions and views are that of the Healthcare Professionals. The news and editorial staff of ET had no role in the creation of this article nor vouch for or endorse any of its content. While the content on this site provides general information about health and wellbeing. It is not intended as medical advice, nor is it a substitute for professional medical expertise or treatment. If you need help getting your health under control, we recommend speaking to your doctor.

Leave a Reply

Your email address will not be published. Required fields are marked *